Published March 23, 2010
| Version v1
Journal article
Open
Phase I dose-escalation study for intravesical instillation of antisense oligonucleotide FFC15-01 against Ki-67 in patients with non muscle invasive bladder cancer
- 1. Charité-Universitätsmedizin Berlin
- 2. University at Lübeck
Description
In this Phase I dose escalation study, we evaluated the pharmacokinetic and toxicity profiles of intravesical instillation of the FFC15-01 Ki-67 antisense oligonucleotide in patients with bladder cancer.
Files
DOBC_2010_2_1_Lingnau_et_al.pdf
Files
(296.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:6027d6b19fe9af8b8e4d4be18f347fa3
|
296.6 kB | Preview Download |